Prelude Capital Management’s Pfenex Inc. PFNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-900
Closed -$8K 2599
2020
Q2
$8K Buy
+900
New +$6.73K ﹤0.01% 1634
2017
Q4
Sell
-17,700
Closed -$53K 1864
2017
Q3
$53K Sell
17,700
-3,000
-14% -$11.4K ﹤0.01% 1087
2017
Q2
$83K Sell
20,700
-2,100
-9% -$9.67K 0.01% 841
2017
Q1
$132K Buy
22,800
+14,900
+189% +$112K 0.01% 696
2016
Q4
$72K Buy
7,900
+7,700
+3,850% +$70.3K 0.01% 941
2016
Q3
$2K Sell
200
-10,300
-98% -$87.9K ﹤0.01% 1541
2016
Q2
$88K Buy
10,500
+6,800
+184% +$54.9K 0.01% 812
2016
Q1
$36K Sell
3,700
-900
-20% -$7.86K 0.01% 1029
2015
Q4
$57K Buy
4,600
+1,300
+39% +$19.2K 0.01% 1012
2015
Q3
$50K Buy
3,300
+2,875
+676% +$58.4K 0.01% 1066
2015
Q2
$8K Buy
+425
New +$7.12K ﹤0.01% 1593

Other funds holding PFNX

Prelude Capital Management's PFNX Position: Q3 2020 in Review

Prelude Capital Management sold out of Pfenex Inc. (PFNX) in Q3 2020, closing a stake of 900 shares — an estimated $8K sold.

Prelude Capital Management first reported a position in PFNX in Q2 2015 and held it in 11 quarters. The position peaked at $132K in Q1 2017. 55 funds tracked by Wall St. Rank hold PFNX as of Q3 2020.

  • Prelude Capital Management reported no remaining Pfenex Inc. position as of Q3 2020 after selling out during the quarter.
  • Prelude Capital Management sold 900 Pfenex Inc. shares in Q3 2020, an estimated $8K.
  • Prelude Capital Management first reported a position in Pfenex Inc. in Q2 2015 and held it in 11 quarters.
  • Prelude Capital Management's Pfenex Inc. position peaked at $132K in Q1 2017.
  • 55 funds tracked by Wall St. Rank held Pfenex Inc. as of Q3 2020.

Based on Prelude Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.